Verified

CAAIF Food Allergy Clinical Research Grant

Canadian Allergy, Asthma, and Immunology Foundation

Description

GRANT OBJECTIVE
The objective of the CAAIF Food Allergy Clinical Research Grant is to support a clinically relevant high-quality research grant focused on food allergy.

VALUE OF THE AWARD
The maximum value of the award is $75,000.

DURATION
The Research Grant is for one year, non-renewable.

APPLICATION DEADLINE
Applications must be submitted by November 3, 2026 at 11:59 pm in the time zone of the applicant

EVALUATION PROCESS
Applications will be screened by CAAIF for eligibility and completeness prior to adjudication. Applications deemed not sufficiently relevant will be removed from the competition. All relevant applications will undergo peer-review evaluation which includes expert reviewers and knowledge users. Evaluations will be based on:

Specific impact and clinical relevance of the project
Scientific strengths of the proposed methodology
Demonstrated ability of applicant/collaborators to realistically achieve proposed project objectives
Appropriateness of budget and timeline for the work proposed

CONDITIONS OF FUNDING

Awardees must acknowledge the assistance given by CAAIF in any publication or presentation made during or resulting from the tenure of the Award.
Applicants may request a one-year no-cost extension. Any unspent funds must be returned to the Partnered Groups immediately on the last day of the requested extension.
A final report must be submitted to CAAIF no later than one year after completion/termination. If this report is not received, awardee will not be eligible for future CAAIF funding opportunitites.
Awardees are strongly encouraged to participate in various requests from the partnered organizations including but not limited to: peer-review, interviews, webinars, virtual appearances and other communications.
These grants do not provide for personal salary support of the Principal Investigator (PI) or Co-applicants, nor for institutional and administrative overhead costs.

AI Based Application Success Predictor

1. Strong alignment with CAAIF research priorities (Highest Predictor ⭐⭐⭐⭐⭐)

This is the most important predictor of success.

Competitive proposals should directly address one or more of CAAIF's priority areas, including:

Asthma
Allergy
Food allergy
Anaphylaxis
Clinical immunology
Immunodeficiency
Hereditary angioedema (for disease-specific calls)
Immune-mediated diseases

Projects should clearly fit the objectives of the specific funding opportunity.

2. High scientific quality and innovation (Highest Predictor ⭐⭐⭐⭐⭐)

CAAIF supports innovative, high-quality research.

Competitive proposals should demonstrate:

Novel hypotheses
Original research questions
Innovative methodologies
Strong scientific rationale
Potential to advance allergy or immunology research

Innovation is emphasized across both basic and clinical grant programs.

3. Clear patient impact and clinical relevance (Highest Predictor ⭐⭐⭐⭐⭐)

Projects should demonstrate the potential to:

Improve prevention
Enhance diagnosis
Develop better treatments
Improve quality of life
Bridge research and clinical care
Improve outcomes for patients with allergic or immunologic diseases

Clinical research proposals should clearly explain how findings could benefit patients.

4. Rigorous scientific methodology and feasibility (Highest Predictor ⭐⭐⭐⭐⭐)

Competitive applications include:

Clearly defined objectives
Robust study design
Appropriate statistical methods
Feasible experimental plan
Clearly defined milestones
Realistic timelines

Strong methodological rigor is fundamental to peer review.

5. Investigator excellence and research environment (Very High Predictor ⭐⭐⭐⭐⭐)

Reviewers consider:

Investigator expertise
Publication record
Research experience
Institutional support
Ability to successfully complete the proposed work

Independent investigators and promising trainees are both supported through different funding mechanisms.

6. Potential to advance Canadian allergy and immunology research (Very High Predictor ⭐⭐⭐⭐⭐)

CAAIF's mission is to strengthen Canada's research capacity.

Competitive proposals should:

Address important Canadian health challenges
Build national expertise
Generate evidence relevant to Canadian patients
Strengthen the allergy and immunology research community

Projects that contribute to long-term research capacity are viewed favorably.

7. Translational research and bridge from laboratory to patient care (Very High Predictor ⭐⭐⭐⭐⭐)

Competitive proposals often include:

Biomarker development
Precision medicine
Translational immunology
Clinical implementation
Diagnostic innovation
Therapeutic development

CAAIF explicitly supports research that bridges laboratory discoveries with clinical practice.

8. Support for early-career investigators and trainees (High Predictor ⭐⭐⭐⭐☆)

CAAIF offers several awards designed for:

Graduate students
Fellows
Early-career investigators
New independent researchers

Applications demonstrating strong mentorship and career development plans are particularly competitive for trainee-focused programs.

9. Equity, Diversity, Inclusion (EDI) and Sex/Gender Integration (High Predictor ⭐⭐⭐⭐☆)

CAAIF is committed to:

Equity, Diversity and Inclusion (EDI)
Fair access to funding
Integration of sex- and gender-based considerations in research where appropriate

Applicants are encouraged to incorporate these elements into study design and analysis when scientifically relevant.

10. Alignment with funding guidelines and realistic budget (High Predictor ⭐⭐⭐⭐☆)

Successful proposals include:

Appropriate budgets
Clear justification of costs
Compliance with eligibility requirements
Complete documentation
Adherence to submission guidelines

Applications that fully meet program requirements are more likely to progress through peer review.

Specialties

Allergy

Immunology

Eligibility Requirements

The award must be held at a Canadian university or research institute defined as an eligible institution by CIHR and the Principal Investigator must hold an academic position at the institution.
Projects must fall within CAAIF's mission.
Preference will be given to investigators who have not received a CAAIF-funded research grant within the past two years.
Investigator-initiated studies of commercial pharmaceutical products eligible for industry sponsorship will not be considered except under special circumstances, and at the discretion of the CAAIF Research Advisory Committee.

Eligible Countries:

Canada

Sponsor Details

Sponsor Institute/Organizations: Canadian Allergy, Asthma, and Immunology Foundation

Sponsor Type: Corporate/Non-Profit

Address: PO Box 1333 Toronto, ON M5M 0A1 info@caaif.ca

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity